Background: An autograft has traditionally been the gold standard for anterior cruciate ligament reconstruction (ACLR), but the use of allograft tissue has increased in recent years. While numerous studies have demonstrated that irradiated allografts are associated with increased failure rates, some report excellent results after ACLR with nonirradiated allografts. The purpose of this systematic review was to determine whether the use of nonirradiated allograft tissue is associated with poorer outcomes when compared with autografts.
Surgical reconstruction of anterior cruciate ligament (ACL) injuries is recommended to restore knee stability and allow patients to return to cutting-and pivoting-type sports. There are many autograft and allograft options for reconstruction, and the decision of which graft type to use is typically based on surgeon and patient preference, patient age, activity level, and desired return to sport. Autografts have traditionally been the gold standard, with the bone-patellar tendon-bone (BPTB) and quadrupled hamstring tendon used most commonly. 24, 28 Allograft use has increased over the past decade mainly because of the avoidance of donor site morbidity, less postoperative pain, and faster operating room time. 27, 31 Disadvantages of allograft use include possible immunogenicity, delayed graft incorporation, and risk of disease transmission. 1, 12, 15 Numerous studies have demonstrated the deleterious effects that irradiation has on the biomechanical properties and failure rates of ACL allografts. 8, 34, 36 A recent metaanalysis by Prodromos et al 33 demonstrated that irradiated allografts have an abnormal stability rate that is 2.5 times that of nonirradiated allografts. Borchers et al 4 showed that the odds of failure after ACL reconstruction with an irradiated allograft were 5.6 times those after reconstruction with an autograft.
Three previous systematic reviews have compared the outcomes of ACL reconstruction using autografts versus allografts. 5, 10, 18 These systematic reviews have varied in terms of their level of evidence, included graft types, and outcomes of interest. A common limitation of each review, however, is the inclusion of irradiated grafts in the allograft group. The purpose of the current systematic review was to determine whether the use of nonirradiated allograft tissue is associated with increased graft failure rates, postoperative laxity on physical examination, and/or poorer patient-reported outcome scores. We hypothesized that ACL reconstruction with nonirradiated allograft tissue was not associated with (1) an increased odds of graft failure as determined clinically or through instrumented laxity testing, (2) increased laxity on postoperative physical examination, or (3) decreased patient-reported outcome scores relative to ACL reconstruction with autograft tissue.
MATERIALS AND METHODS

Eligibility Criteria
All English-language prospective or retrospective comparative studies (evidence level 1, 2, or 3) comparing outcomes of primary ACL reconstruction with autograft tissue versus nonirradiated allograft tissue were eligible for inclusion in this review. Studies were excluded if it was not clearly stated whether the allograft had been irradiated. Patients of all ages were included. Each study was required to have a minimum of 15 patients in each group and a mean follow-up of at least 2 years. Outcome data including clinical or instrumented failure rates or patient-reported outcome scores were required for inclusion.
Literature Search and Study Selection
Literature review included a search of Scopus, Embase, CINAHL, and Cochrane Collaboration systematic reviews through October 12, 2012. Two independent reviewers (M.W.M. and D.M.) separately completed the search. Search terms included ''autograft,'' ''allograft,'' and ''anterior cruciate ligament.'' This search yielded a total of 649 studies across all databases. After applying a filter to include only human, English-language, and comparative autograft and allograft studies, 114 studies remained. The title and abstract of all 114 studies were reviewed, and 36 duplicate studies were removed. Of the 78 remaining studies, 57 were excluded for the following reasons: study unrelated to the research question (n = 24), studies not published in the English language (n = 8), cost-effectiveness analyses (n = 6), studies comparing 2 types of allograft (n = 5), review papers with no original data (n = 4), animal studies (n = 4), papers focused on infection rates (n = 2), short follow-up (n = 2), 1 opinion/survey paper, and 1 paper utilizing nonstandard graft processing. This left a total of 21 comparative studies. Twelve of the 21 studies were excluded for not specifying whether the allografts had been irradiated (n = 6) 2, 21, 22, 25, 29, 33 or including allografts that had been irradiated (n = 6). 6, 11, 26, 36, 37, 39 The 9 remaining studies compared autograft and nonirradiated allograft tissue. z The reference section of each included study was reviewed to ensure that no studies were missed in the literature review. The literature search is summarized in Figure 1 . References 3, 9, 13, 17, 19, 20, 32, 38, 40. y of origin, procedure date range, number of surgeons, number of eligible patients, percentage of eligible patients with follow-up, mean follow-up time, study design, patient demographics, whether the injury involved a sports mechanism, time from injury to reconstruction, graft choice, surgical technique and graft fixation, physical examination findings, the use of independent and/or blinded examiners, clinical failure rates, instrumented laxity measurements (KT-1000 or KT-2000 arthrometer), and patient-reported outcome scores.
Data Extraction
Methodological Quality Assessment
Two authors (M.W.M. and D.M.) separately graded the methodological quality of each eligible study using the Delphi list quality score and modified Coleman methodology score. The Delphi scoring system was based on 9 questions: Was a method of randomization used? Was the treatment allocation concealed? Were the groups similar at baseline? Were eligibility criteria specified? Was the outcome assessor blinded? Was the care provider blinded? Was the patient blinded? Were point estimates and measures of variability used? Was there an intention-to-treat analysis? Each question was given 1 point for ''yes,'' 1 point was deducted for ''no,'' and 0 points were given for ''don't know.'' 42 The modified Coleman score included questions on study size, mean followup, percentage of patients with follow-up, number of interventions per group, study type, diagnostic certainty of ACL tear, description of ACL reconstruction procedure, description of postoperative rehabilitation, specifications of outcome criteria, procedures for assessing outcomes, and description of patient selection process. 7, 23 The modified Coleman methodology score was based on a scaled maximum of 100 points. The study's rating was considered excellent if the score was 85 to 100 points, good if it was 70 to 84 points, fair if it was 55 to 69 points, and poor if it was 54 points.
Statistical Analysis
Each outcome measure (graft failure as determined clinically or via instrumented laxity as well as patient-reported outcome scores) was qualitatively assessed for homogeneity. In cases of qualitative homogeneity, statistical testing of homogeneity (x 2 ) was performed. If the observed variation was inconsistent with the null hypothesis (P \ .1), no meta-analysis was performed. In cases in which data were qualitatively heterogeneous, no statistical analysis of heterogeneity was performed. For outcome variables sufficiently homogeneous for meta-analysis, a Mantel-Haenszel analysis utilizing a random-effects model was used to pool results according to graft tissue (allograft vs autograft) while accounting for the number of patients in individual studies. 35 
RESULTS
Study Characteristics and Outcomes
Of the 9 included studies, 6 studies were level 2 9, 17, 20, 32, 38, 40 and 3 studies were level 3. 3, 13, 19 Of the 6 level 2 studies, 3 were randomized controlled trials 20, 38, 40 ( Table 1 ). Six of the 9 studies compared BPTB autografts and BPTB allografts. Two studies compared quadrupled hamstring tendon autografts and quadrupled hamstring tendon allografts, and 1 study compared quadrupled hamstring tendon autografts and anterior tibialis allografts ( Table 2 ). The number of patients with follow-up ranged from 60 to 186. The mean follow-up duration ranged from 24 to 94 months. The mean patient age in 7 of 9 studies ranged from 24.5 to 32 years; 1 study reported a patient age of 40 to 54 years with no actual average, and another study did not report patient age (Table 3) .
Clinical failure risk was reported in 6 of 9 studies, while instrumented laxity measurements were reported in 8 of 9 studies. Lachman test results were reported in 5 of 9 studies, and pivot-shift test results were reported in 7 of 9 studies. Patient-reported outcome scores were reported in all 9 studies and included the Lysholm, Cincinnati, International Knee Documentation Committee (IKDC) subjective, and Tegner activity scores. 14, 30, 41 
Study Methodological Quality
The Delphi list quality scores and the modified Coleman methodology scores were calculated for all 9 studies (see the Appendix, available in the online version of this article at http://ajsm.sagepub.com/supplemental). Based on the scaled maximum of 100 points, the mean overall modified Coleman score for the 9 studies was 67. Two studies were categorized as excellent, 1 study was categorized as good, 4 studies were categorized as fair, and 2 studies were categorized as poor.
Failure Risk
Clinical failure risk (as defined by the authors) was compared between autografts and allografts in 6 studies. According to this definition of failure, the overall failure risk across the 6 studies was 3.0% (6/198) in the autograft group and 2.4% (6/251) in the allograft group. Metaanalysis indicated no increased risk of graft failure in the allograft group (Figure 2) . Failure risk as determined by instrumented laxity measurements was compared between autografts and allografts in 8 studies. Failure was defined as anterior laxity of at least 5 mm greater than the contralateral side. According to this definition of failure, the overall failure risk across the 8 studies was 6.0% (22/364) in the autograft group and 5.5% (24/ 437) in the allograft group. Meta-analysis indicated no increased risk of graft failure in the allograft group (Figure 3 ).
Laxity on Physical Examination
Anterior laxity as assessed with the Lachman examination was reported in 5 studies. No study noted a statistically significant difference between the autograft and allograft groups ( Table 4 ). Meta-analysis indicated no difference in the risk of having a Lachman grade greater than 0 between the 2 treatment groups (Figure 4 ).
Rotational laxity as assessed with the pivot-shift examination was reported in 5 studies. No study noted a statistically significant difference between the autograft and allograft groups ( Table 5 ). Meta-analysis indicated no difference in the risk of having a pivot shift greater than 0 between the 2 treatment groups ( Figure 5 ). The Harner 
Patient-Reported Outcome Scores
Patient-reported outcome scores were reported in every study. All studies used the Lysholm or subjective IKDC score. Five studies used both scoring systems. The Cincinnati knee score was also used in 3 of the 9 studies. The Tegner activity score was reported in 6 studies. There was no statistically significant difference between autograft and allograft reconstructions in any patient-reported outcome score in any study ( Table 6 ). 
DISCUSSION
This systematic review is the first to compare outcomes of ACL reconstruction with autograft versus exclusively nonirradiated allograft tissue. This review demonstrates no statistically significant difference between autografts and nonirradiated allografts with regard to failure risk, physical examination findings, or patient-reported outcome scores. It is critically important to note that the results of this study can only be applied to patient populations that are similar to the patients included in the source studies. Mean patient age in the studies was generally in the late 20s to early 30s, with 1 study focused on patients in their 40s. It has also been shown that the risk of graft failure decreases with increasing age. 16 Therefore, the studies in this systematic review did not evaluate allograft use in the highest risk population for graft failure, and this fact could bias the findings. Application of the findings of this study to a younger, more active population would not be appropriate. Literature review demonstrated only 1 study that stratified outcomes based on age and activity level. Barrett et al 2 showed at a minimum 2-year follow-up that patients younger than 25 years (mean age, 18 years) had significantly increased failure rates regardless of graft type. Reported failure rates for patients younger than 25 years were 12% for patellar tendon autografts, 25% for hamstring tendon autografts, and 29% for allografts. In the allograft group, a combination of the patellar tendon and posterior tibialis were used, but it was not reported whether the allografts had been irradiated. In contrast, there was no statistically significant difference in failure rates among patients older than 25 years (mean age, 39 years) with different graft types.
The results of the current review are similar to previously published meta-analyses and systematic reviews comparing autograft and allograft usage in ACL reconstruction. 5, 10, 18 The most recent review identified 31 prospective studies that included either autograft patients alone (27 studies) or autograft and allograft groups (4 studies). 10 After pooling the data, the authors could not find any statistically significant difference in laxity or IKDC scores between groups. Although graft failure rates were noted to be 4.7 per 100 for autograft reconstructions and 8.2 per 100 for allograft reconstructions, this trend did not reach statistical significance. Carey et al 5 included 9 autograft versus allograft comparative studies. Three of the studies included irradiated allografts, while 1 did not report whether irradiation was used. They showed no significant difference in Lysholm scores and instrumented laxity measurements between the groups. Clinical failure was noted in 5 of 230 clinical failures in the autograft group and 11 of 240 in the allograft group, which was not statistically significant. Krych et al 18 performed a systematic review of 6 prospective nonrandomized cohort studies comparing patellar tendon autografts and patellar tendon allografts. When irradiated and chemically processed allografts were excluded, there was no significant difference in IKDC scores, Lachman/pivot-shift testing, graft rupture, or rate of reoperation.
Strengths of this study include the exclusive use of comparative studies and the inclusion of only studies that utilized nonirradiated allografts. These relatively homogeneous data allowed for meta-analysis and resulted in clear evidence that nonirradiated allografts do not compromise the results of ACL reconstruction in the population analyzed. The key limitation of this study is the inability to comment on the effect or role of nonirradiated allograft tissue in a younger, more active patient population. An additional limitation is that the majority of studies included in the review utilized patellar tendon grafts. It is unknown whether results would differ if younger patients and soft tissue grafts were more numerous in the dataset.
CONCLUSION
There were no significant differences in graft failure rate, postoperative laxity, or patient-reported outcome scores when comparing ACL reconstruction with autografts to nonirradiated allografts in this systematic review. These findings apply to patients in their late 20s and early 30s. We caution against extrapolating these findings to younger, more active cohorts.
An online CME course associated with this article is available for 1 AMA PRA Category 1 Credit TM at http://ajsm-cme.sagepub.com. In accordance with the standards of the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of The American Orthopaedic Society for Sports Medicine that authors, editors, and planners disclose to the learners all financial relationships during the past 12 months with any commercial interest (A 'commercial interest' is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients). Any and all disclosures are provided in the online journal CME area which is provided to all participants before they actually take the CME activity. In accordance with AOSSM policy, authors, editors, and planners' participation in this educational activity will be predicated upon timely submission and review of AOSSM disclosure. Noncompliance will result in an author/editor or planner to be stricken from participating in this CME activity. 
